HomeNewsBusinessReal EstateWarehouse inventory likely to shoot past 380 million sq ft by 2024: JLL study

Warehouse inventory likely to shoot past 380 million sq ft by 2024: JLL study

Ongoing structural changes to asset allocations and operations of logistics real estate and supply chain networks have accelerated investment into the sector

November 29, 2021 / 14:57 IST
Story continues below Advertisement
(Image courtesy: Embassy Industrial Parks)
(Image courtesy: Embassy Industrial Parks)

With increased activity in sectors like e-commerce and 3PL/logistics, the warehouse inventory in the country is expected to reach over 380 million sq ft by 2024, according to JLL.

About 27 million sq ft of warehousing stock was added in first nine months (January-September) of 2021, bringing the total stock to 265 million sq ft in 2021. The total stock of Grade A and B warehousing space in the top eight cities posted a CAGR of 16 percent from 2018 to YTD 2021 (till Q3, 2021), it said.

Story continues below Advertisement

“Growth in the supply of Grade-A spaces over the years is due to high demand for spaces with high specifications, citing increased inclination for high-grade structures and introduction of new players in the market,” said Yogesh Shevade, Head of Logistics and Industrial, India, JLL.

According to him, the Indian market has now firmly established itself for a more predominant position in Grade-A space as opposed to Grade-B space.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show